Company / Depreciation & Amortization
Thermo Fisher Scientific Depreciation & Amortization History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$831.0M
FY2023
5-year range
$564.0M / $831.0M
FY2019-FY2023
Trend
+26.3%
vs FY2022
Sector context
#17 of 142
Health Care
What the data says
Thermo Fisher Scientific's depreciation & amortization of $831M is higher than 88% of companies in the Health Care sector (FY2023). Increased from $564M to $831M over the past 2 years.
Based on SEC 10-K filings.
$831M in FY2023 with a 5-year CAGR of -18.2%. Top quartile in the Health Care sector.
Increased from $564M to $831M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -18.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 142This company $831.0M Sector average $347.4M
▼
+139.2% above sector average
Key checks
Key Insights
- 5-year CAGR of -18.2%, indicating a declining trend.
- In FY2023, depreciation & amortization increased 26.3% year-over-year.
- Ranks #17 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2018.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $831.0M | +26.3% |
| FY2022 | $658.0M | +16.7% |
| FY2021 | $564.0M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $2.3B | +11.5% |
| FY2017 | $2.0B | +15.6% |
| FY2016 | $1.8B | +4.1% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026